385275000: Cutaneous AND/OR transdermal dosage form (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

1479527018 Cutaneous AND/OR transdermal dosage form en Synonym Active Only initial character case insensitive SNOMED CT core module

2660179010 Cutaneous AND/OR transdermal dosage form (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Cutaneous AND/OR transdermal dosage form	Is a	Type of drug preparation	false	Inferred relationship	Existential restriction modifier
Cutaneous AND/OR transdermal dosage form	Is a	Dose form by site prepared for	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Amorolfine 5% nail lacquer	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Coal tar extract 2% shampoo	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely coal tar 43 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Soya oil 84.75% bath oil	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely lidocaine 50 microgram/1 milligram conventional release cutaneous patch (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 40micrograms/activation iontophoretic transdermal system	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Epinephrine 1:1000 1mg/mL topical solution	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely salicylic acid 30 milligram/1 milliliter and sulfur 50 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Malathion 1% cream shampoo	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely povidone iodine 40 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Salicylic acid 17% liquid	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Soya oil+mixed lauromacrogols 82.95/15% bath oil	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Povidone-iodine 10% paint	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely selenium sulfide 25 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Alcoholic coal tar extract 5% shampoo	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely ketoconazole 20 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone 1% / Potassium hydroxyquinoline sulphate 0.5% cream	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 40micrograms/activation iontophoretic transdermal system	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Malathion 1% cream shampoo	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Salicylic acid 17% liquid	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Soya oil 84.75% bath oil	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely salicylic acid 30 milligram/1 milliliter and sulfur 50 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely lidocaine 50 microgram/1 milligram conventional release cutaneous patch (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Povidone-iodine 10% paint	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Epinephrine 1:1000 1mg/mL topical solution	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Amorolfine 5% nail lacquer	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely ketoconazole 20 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely coal tar 43 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Soya oil+mixed lauromacrogols 82.95/15% bath oil	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Alcoholic coal tar extract 5% shampoo	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Coal tar 40% bath emulsion	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely selenium sulfide 25 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Product containing precisely povidone iodine 40 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Coal tar extract 2% shampoo	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Soya oil 82.95% / Lauromacrogols 15% bath oil	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Coal tar extract 5% shampoo	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Amorolfine 5% medicated nail lacquer	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 40micrograms/dose transdermal system	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Adrenaline (base) 1mg/ml (1 in 1,000) topical solution	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 25micrograms/hour patches (Teva UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 50micrograms/hour patches (Teva UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 75micrograms/hour patches (Teva UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 100micrograms/hour patches (Teva UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 25micrograms/hour patches (Teva UK Ltd) 5 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 50micrograms/hour patches (Teva UK Ltd) 5 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 75micrograms/hour patches (Teva UK Ltd) 5 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 100micrograms/hour patches (Teva UK Ltd) 5 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Solaraze 3% gel (PI) (Waymade Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Solaraze 3% gel (PI) (Waymade Ltd) 25 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Oruvail 2.5% gel (PI) (Waymade Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Oruvail 2.5% gel (PI) (Waymade Ltd) 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Piroxicam 0.5% gel (Dr Reddy's Labs)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Piroxicam 0.5% gel (Dr Reddy's Labs) 112 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Piroxicam 0.5% gel (Dr Reddy's Labs) 60 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Matrifen 25micrograms/hour transdermal patches (Nycomed (UK) Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Matrifen 50micrograms/hour transdermal patches (Nycomed (UK) Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Matrifen 75micrograms/hour transdermal patches (Nycomed (UK) Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Matrifen 100micrograms/hour transdermal patches (Nycomed (UK) Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Matrifen 25micrograms/hour transdermal patches (Nycomed (UK) Ltd) 5 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Matrifen 50micrograms/hour transdermal patches (Nycomed (UK) Ltd) 5 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Matrifen 75micrograms/hour transdermal patches (Nycomed (UK) Ltd) 5 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Matrifen 100micrograms/hour transdermal patches (Nycomed (UK) Ltd) 5 patch	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Piroxicam 0.5% gel (Teva UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Piroxicam 0.5% gel (Teva UK Ltd) 60 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Piroxicam 0.5% gel (Teva UK Ltd) 112 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Movelat cream (Waymade Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Movelat cream (Waymade Ltd) 100 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Aciclovir 5% cream (Pliva Pharma Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Clotrimazole 1% cream (Pliva Pharma Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ketoprofen 2.5% gel (Almus Pharmaceuticals Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Piroxicam 0.5% gel (Pliva Pharma Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Aciclovir 5% cream (Pliva Pharma Ltd) 10 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Clotrimazole 1% cream (Pliva Pharma Ltd) 20 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Clotrimazole 1% cream (Pliva Pharma Ltd) 50 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ketoprofen 2.5% gel (Almus Pharmaceuticals Ltd) 30 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ketoprofen 2.5% gel (Almus Pharmaceuticals Ltd) 50 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Piroxicam 0.5% gel (Pliva Pharma Ltd) 60 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Piroxicam 0.5% gel (Pliva Pharma Ltd) 112 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Zinc sulphate 1% lotion (Special Order)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Zinc sulphate 1% lotion 1 ml	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Zinc sulphate 1% lotion (Special Order) 1 ml	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Cocaine hydrochloride 4% topical solution (Roxane Laboratories, Inc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Cocaine hydrochloride 4% topical solution 4 ml	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Cocaine hydrochloride 4% topical solution (Roxane Laboratories, Inc) 4 ml	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fluocinolone 0.025% gel 60 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Calcipotriol 50micrograms/g ointment (Sandoz Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Clotrimazole 1% cream (Sandoz Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Calcipotriol 50micrograms/g ointment (Sandoz Ltd) 120 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Clotrimazole 1% cream (Sandoz Ltd) 20 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Eldoquin 2% cream (Crawford Pharmaceuticals)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydroquinone 2% cream 28 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Eldoquin 2% cream (Crawford Pharmaceuticals) 28 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Calcipotriol 50micrograms/g ointment (UniChem Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Calcipotriol 50micrograms/g ointment (UniChem Ltd) 120 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrogen peroxide 1% cream 40 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Calcipotriol 50micrograms/g ointment (A A H Pharmaceuticals Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Calcipotriol 50micrograms/g ointment (A A H Pharmaceuticals Ltd) 120 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Dual Action Athlete's Foot powder (The Boots Company Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Tolnaftate 1% / Chlorhexidine 0.25% powder 75 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Dual Action Athlete's Foot powder (The Boots Company Plc) 75 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Diclofenac diethylammonium 1.16% gel 50 gram	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier

Start Previous Page 14 of 55 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1479527018	Cutaneous AND/OR transdermal dosage form	en	Synonym	Active	Only initial character case insensitive	SNOMED CT core module
2660179010	Cutaneous AND/OR transdermal dosage form (qualifier value)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT core module